Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial - Concepedia

Concepedia

Publication | Open Access

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial

DOI Full Paper Access

71

Citations

32

References

2016

Year

Mwayiwawo Madanitsa, Linda Kalilani, Victor Mwapasa, Anna Maria van Eijk, Carole Khairallah, Doreen Ali, Cheryl Pace, James Smedley, Kyaw-Lay Thwai, Brandt Levitt,

Abstract

Pan African Clinical Trials Registry PACTR201103000280319; ISRCTN Registry ISRCTN69800930.

References

	Year	Citations
New Ballard Score, expanded to include extremely premature infants J. Ballard, Jane Khoury, Kathy E. Wedig, The Journal of Pediatrics NeonatologyEarly Childhood DevelopmentPediatricsNew Ballard ScoreEducation	1991	2K
Epidemiology and burden of malaria in pregnancy Meghna Desai, Feiko O. ter Kuile, Bernard J. Brabin, The Lancet Infectious Diseases	2007	1.2K
Epidemiology and burden of malaria in pregnancy. Meghna Desai, Feiko O. ter Kuile, François Nosten, LSTM Online Archive (Liverpool School of Tropical Medicine)	2007	1K
Competitive facilitation of drug-resistant <i>Plasmodium falciparum</i> malaria parasites in pregnant women who receive preventive treatment Whitney E. Harrington, Theonest K. Mutabingwa, Atis Muehlenbachs, Proceedings of the National Academy of Sciences Antiparasitic AgentMalariaPharmacotherapyParasite GenomicsDrug Resistance	2009	202
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin–piperaquine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial Meghna Desai, Julie Gutman, Anne L’lanziva, The Lancet Preventive MedicineIntermittent ScreeningSuperiority TrialMaternal ComplicationMalaria	2015	198
Maternal Malaria and Gravidity Interact to Modify Infant Susceptibility to Malaria Theonest K. Mutabingwa, Melissa C Bolla, Jinlong Li, PLoS Medicine	2005	181
Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight Meghna Desai, Julie Gutman, Steve M. Taylor, Clinical Infectious Diseases	2015	178
Maternal Placental Infection with Plasmodium falciparum and Malaria Morbidity during the First 2 Years of Life Jean‐Yves Le Hesran, Michel Cot, P. Personne, American Journal of Epidemiology	1997	169
Can Prenatal Malaria Exposure Produce an Immune Tolerant Phenotype?: A Prospective Birth Cohort Study in Kenya Indu Malhotra, Arlene E. Dent, Peter Mungai, PLoS Medicine	2009	155
Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial Raquel González, Ghyslain Mombo‐Ngoma, Smaïla Ouédraogo, PLoS Medicine	2014	132

Page 1